-
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a British-Swedish
multinational pharmaceutical and
biotechnology company with its
headquarters at the Cambridge...
- The Oxford–
AstraZeneca COVID‑19 vaccine, sold
under the
brand names Covishield and
Vaxzevria among others, is a
viral vector vaccine for the prevention...
-
recognized by the
World Health Organization (WHO): Pfizer–BioNTech, Oxford–
AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia...
- results" (PDF).
AstraZeneca. "Full year and Q4 2023 results" (PDF).
AstraZeneca. "Full year and Q4 2022 results" (PDF).
AstraZeneca. "Full year and Q4...
-
Stock Exchange. In 1999,
Zeneca and the Sweden-based
pharmaceutical company Astra AB
merged to form
AstraZeneca plc.
Zeneca's largest therapeutic area...
- by
Swedish AB Hässle, part of
Astra AB. It was the
first of the
proton pump
inhibitors (PPI).
Astra AB, now
AstraZeneca,
launched it as an
ulcer medicine...
- PMC 8143907. PMID 34062319. "
AstraZeneca COVID-19
Vaccine (AZD1222)" (PDF). ACIP COVID-19
Emergency Meeting.
AstraZeneca. 27
January 2021.
Archived (PDF)...
- into a new and
independent company called Zeneca.
Zeneca subsequently merged with
Astra AB to form
AstraZeneca. In 1994,
Charles Miller Smith was appointed...
-
partnered with the British-Swedish
multinational pharmaceutical company AstraZeneca for
developing AZD1222 (Covishield) in
partnership with the University...
- This was amid
concerns about the
AstraZeneca vaccine, in rare cases,
causing blood clots; see
section Oxford–
AstraZeneca vaccine below. The
additional doses...
